MedTrace Logo

Antihypertensive Medication Exposure as Risk for Impaired Glucose Tolerance: A PEAR Sub-Study

NCT01099397 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2018-04-03

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if, in a subset of patients treated with a beta-blocker and diuretic, prediabetes is detectable to a greater extent through a 2-hour oral glucose tolerance test (OGTT) compared to fasting glucose measurement.

Conditions

  • Prediabetic State

Interventions

OTHER

Oral glucose tolerance test

For assessment of dysglycemia, 75 grams of glucose solution by mouth at 3 PEAR study visits for all enrolled participants: baseline, single drug therapy assessment, and dual drug therapy assessment.

Sponsors & Collaborators

  • University of Florida

    lead OTHER

Principal Investigators

  • Julie A Johnson, PharmD · University of Florida

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01099397 on ClinicalTrials.gov